Anthony H. Schapira
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies?
Journal: Journal of Parkinson's disease
Published: April 21, 2026
The role of dopaminergic medication and specific pathway alterations in idiopathic and PRKN/PINK1-mediated Parkinson's disease.
Journal: Science advances
Published: May 14, 2025
The lysosomotrope GPN mobilises Ca2+ from acidic organelles.
Journal: Journal of cell science
Published: November 03, 2020
GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2).
Journal: Neuromuscular disorders : NMD
Published: August 29, 2017
DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.
Journal: PloS one
Published: February 04, 2017
Endo-lysosomal TRP mucolipin-1 channels trigger global ER Ca2+ release and Ca2+ influx.
Journal: Journal of cell science
Published: April 15, 2016
Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 18, 2012
Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signals.
Journal: Journal of cell science
Published: October 31, 2012
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage.
Journal: Neurochemistry international
Published: April 04, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026